@article{article, title  = {{Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/137968 }},

 year = {{2018}},

 month = {{9}},

 author = {{Tappenden P and Simpson E and Hamilton J and Pollard D and Clowes M and Kaltenthaler E and Meiklejohn D and Morley N}},

 doi = {{10.1007/s40273-018-0713-7}},

 volume = {{37}},

 journal = {{PharmacoEconomics}},

 issue = {{3}},

 pages = {{333-343}},

 note = {{Accessed on 2025/11/19}}}